Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure

Details for Australian Patent Application No. 2010200833 (hide)

Owner Novartis AG

Inventors Feldman, David Louis; Luft, Friedrich Cameron; Mueller, Dominik Nicolas; Webb, Randy Lee

Agent Davies Collison Cave

Pub. Number AU-B-2010200833

Parent 2005294318

Filing date 4 March 2010

Wipo publication date 1 April 2010

Acceptance publication date 14 July 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/401 (2006.01) - Proline

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

25 March 2010 Complete Application Filed

1 April 2010 Application Open to Public Inspection

  Published as AU-B-2010200833

14 July 2011 Application Accepted

  Published as AU-B-2010200833

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200834-Air conditioner

2010200832-Eye protectors